BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37848262)

  • 1. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
    Scirocco C; Ferrigno S; Andreoli L; Fredi M; Lomater C; Moroni L; Mosca M; Raffeiner B; Carrara G; Landolfi G; Rozza D; Zanetti A; Scirè CA; Sebastiani GD
    Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37848262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
    Hasseli R; Pfeil A; Hoyer BF; Krause A; Lorenz HM; Richter JG; Schmeiser T; Voll RE; Schulze-Koops H; Specker C; Müller-Ladner U
    Clin Exp Rheumatol; 2021; 39(3):639-647. PubMed ID: 33822706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
    Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A
    J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
    Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
    Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
    Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective.
    Zamora-Abrahan GT; Salido EO; Lichauco JJT; Gutierrez-Rubio AKM; Rivera-Go ICT; Cortez KJC; Suilan KEA; Villo JGB; Del Rosario AG
    Clin Rheumatol; 2023 Apr; 42(4):1171-1175. PubMed ID: 36637634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis.
    Wang P; Ni J; Chu YY; Chen QQ; Wu GC; Fang Y; Chen C; Zhang RD; Jiang LQ; Zhao Y; Fang X; He J; Wang DG; Wang GH; Pan HF
    Biomed Pharmacother; 2022 Jun; 150():112997. PubMed ID: 35486976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
    Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
    Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
    Ugarte-Gil MF; Alarcón GS; Izadi Z; Duarte-García A; Reátegui-Sokolova C; Clarke AE; Wise L; Pons-Estel GJ; Santos MJ; Bernatsky S; Ribeiro SLE; Al Emadi S; Sparks JA; Hsu TY; Patel NJ; Gilbert EL; Valenzuela-Almada MO; Jönsen A; Landolfi G; Fredi M; Goulenok T; Devaux M; Mariette X; Queyrel V; Romão VC; Sequeira G; Hasseli R; Hoyer B; Voll RE; Specker C; Baez R; Castro-Coello V; Maldonado Ficco H; Reis Neto ET; Ferreira GAA; Monticielo OAA; Sirotich E; Liew J; Hausmann J; Sufka P; Grainger R; Bhana S; Costello W; Wallace ZS; Jacobsohn L; Taylor T; Ja C; Strangfeld A; Mateus EF; Hyrich KL; Carmona L; Lawson-Tovey S; Kearsley-Fleet L; Schäfer M; Machado PM; Robinson PC; Gianfrancesco M; Yazdany J
    Ann Rheum Dis; 2022 Jul; 81(7):970-978. PubMed ID: 35172961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Polyautoimmunity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    Ordoñez-Cañizares MC; Mena-Vázquez N; Redondo-Rodriguez R; Manrique-Arija S; Jimenez-Núñez FG; Ureña-Garnica I; Fernández-Nebro A
    J Clin Rheumatol; 2022 Jan; 28(1):e38-e43. PubMed ID: 32956154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes and contraceptive use in patients with systemic lupus Erythematosus, rheumatoid arthritis and women without a chronic illness: a comparative study.
    Galappatthy P; Jayasinghe JDD; Paththinige SC; Sheriff RMH; Wijayaratne LS
    Int J Rheum Dis; 2017 Jun; 20(6):746-754. PubMed ID: 28205395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
    Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Zonana-Nacach A; Santana-Sahagún E; Jiménez-Balderas FJ; Camargo-Coronel A
    J Clin Rheumatol; 2008 Apr; 14(2):74-7. PubMed ID: 18391674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series.
    Colmegna I; Valerio V; Amiable N; Useche M; Rampakakis E; Flamand L; Rollet-Labelle E; Bessette L; Fitzcharles MA; Hazel E; McCormack D; Michou L; Panopalis P; Langlois MA; Bernatsky S; Fortin PR
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 38030231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of a uniform record keeping practice for rheumatology clinics in Sri Lanka-an ILAR project.
    Deshapriya K
    Clin Rheumatol; 2019 Jan; 38(1):159-164. PubMed ID: 30280370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study.
    Fong W; Woon TH; Chew LC; Low A; Law A; Poh YJ; Yeo SI; Leung YY; Ma M; Santosa A; Kong KO; Xu C; Teng GG; Mak A; Tay SH; Chuah TY; Roslan NE; Angkodjojo S; Phang KF; Sriranganathan M; Tan TC; Cheung P; Lahiri M
    Adv Rheumatol; 2023 Aug; 63(1):38. PubMed ID: 37528453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study.
    Rabe APJ; Loke WJ; Kalyani RN; Tummala R; Stirnadel-Farrant HA; Were J; Winthrop KL
    BMJ Open; 2023 Nov; 13(11):e071072. PubMed ID: 37993165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.